Our Products
Our Products

MyHep All

MyHep All

Generic:

Sofosbuvir, Velpatasvir

 

Therapeutic Class:

Hepatitis C Antivirals

 

Composition:

Each MyHep All tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg.

 

Description:

MyHep All is a fixed-dose combination tablet containing sofosbuvir and velpatasvir for oral administration. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor.

 

Indications:

MyHep All is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection. 

 

Dosage:

The recommended dosage of MyHep All is one tablet taken orally once daily with or without food.

 

Presentation:

MyHep All Tab is available in a pack of 28’s.